Scientific expertise

Our gene work is based on the Two-Layered DAPCEL™ RC (Rare Codon) gene-optimization approach. It takes rare codons and translation kinetics into account and is designed to favor soluble, correctly folded protein expression.

We also produce recombinant proteins and verify their function, develop bioassays, and test the biological activity of proteins, whether we made them or a customer supplies them.

Services and products

Research and experience

Studies that used DAPCEL-optimized genes range from translation initiation and spliceosome structure to genome editing, histone recognition by bromodomains, and ovarian cancer vaccines. Dapcel proteins, Oncostatin M in particular, have been used in published studies of cytokine signaling in cancer cells.

See the publications

2010
First peer-reviewed study using DAPCEL gene redesign: Skabkin et al., Genes Dev. 24, 1787–1801.
19
Published studies, from 2010 to 2024, that used DAPCEL-optimized genes (listed on the Publications page).
9
Academic institutions for which Dapcel is a certified vendor (listed on the Partners page, with our industrial partners, licensees and memberships).

Cleveland, Ohio

11000 Cedar Ave, Suite 110
Cleveland, OH 44106-3069
Mon–Fri, 9:00 AM–6:00 PM ET

Discuss your project

Send a sequence, construct, protein sample or assay question. The scientist who would do the work reviews it and replies, typically within one business day.

Request a quote